UNCY Unicycive Therapeutics, Inc. (UNCY) Reports FY2025 Earnings 2 weeks ago Unicycive Therapeutics, Inc. (UNCY) posted Q4 2025 basic and diluted EPS of -$1.67. Unicycive CEO On Kidney Care Focus 3 months ago Dr. Shalabh Gupta, CEO of Unicycive Therapeutics, discusses the company's focus on kidney care and its lead drug candidate for…
